Welche nicht invasive Bildgebung: funktionell oder morphologisch?

Zusammenfassung

Die moderne nicht invasive Bildgebung ergänzt die klinische Beurteilung und Basisdiagnostik bei Patienten mit Verdacht auf KHK oder bereits manifester Erkrankung. Grundlage der Bildgebung bildet die transthorakale Echokardiografie. Zur erweiterten Diagnostik steht ein Spektrum von Methoden (CT-Angiografie, Stressechokardiografie, CMR, SPECT, PET) zur Verfügung. Hierbei ist die Auswahl der geeigneten Methode im Sinne einer „differenzierten Indikationsstellung“ entscheidend für die optimierte Diagnostik und Therapie.

Abstract

Optimized clinical diagnostics and therapy of patients with (suspected) coronary artery disease requires – beside clinical assessment and basic diagnostics – non-invasive cardiovascular imaging. In most patients transthoracic echocardiography is the method of choice to assess basic cardiac function and structural abnormalities. The choice of the optimal additional imaging method (CT-angiography, stress echocardiography, CMR, SPECT, PET) requires careful assessment by the physician and is crucial for diagnosis and therapy.

Schlüsselwörter

koronare Herzkrankheit - nicht invasive Bildgebung - Ischämietestung

Key words

coronary artery disease - non-invasive cardiac imaging - ischemia testing

• Literatur

• 1 Go AS, Mozaffarian D, Roger VL et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 2014; 129: 399-410
• 2 OʼMahony MS, Sim MF, Ho SF et al. Diastolic heart failure in older people. Age Ageing 2003; 32: 519-524
• 3 Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: evolving knowledge. J Am Coll Cardiol 2009; 54: 1561-1575
• 4 Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34: 2949-3003
• 5 Buck T, Breithardt OA, Faber L et al. Erratum zu: Manual zur Indikation und Durchfuhrung der Echokardiographie. Clin Res Cardiol 2010; [Epub ahead of print]; PMID: 20082081
• 6 Yilmaz A, Sechtem U. Ischaemia testing in patients with stable angina: which test for whom?. Heart 2014; 100: 1886-1896
• 7 Genders TS, Steyerberg EW, Alkadhi H et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 2011; 32: 1316-1330
• 8 American College of Cardiology Foundation Task Force on Expert Consensus Documents. Mark DB, Berman DS, Budoff MJ et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 2010; 121: 2509-2543
• 9 Abbara S, Arbab-Zadeh A, Callister TQ et al. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2009; 3: 190-204
• 10 Heijenbrok-Kal MH, Fleischmann KE, Hunink MG. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. Am Heart J 2007; 154: 415-423
• 11 Reilly JP, Tunick PA, Timmermans RJ et al. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000; 35: 485-490
• 12 BfArM. Schwefelhexafluorid (SonoVue®) Rote Hand Brief 2014.
• 13 Senior R, Moreo A, Gaibazzi N et al. Comparison of sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography with gated single-photon emission computed tomography for detection of significant coronary artery disease: a large European multicenter study. J Am Coll Cardiol 2013; 62: 1353-1361
• 14 Voigt JU, Exner B, Schmiedehausen K et al. Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 2003; 107: 2120-2126
• 15 Yilmaz A, Athanasiadis A, Mahrholdt H et al. Diagnostic value of perfusion cardiovascular magnetic resonance in patients with angina pectoris but normal coronary angiograms assessed by intracoronary acetylcholine testing. Heart 2010; 96: 372-379
• 16 Greenwood JP, Motwani M, Maredia N et al. Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial. Circulation 2014; 129: 1129-1138
• 17 Achenbach S, Barkhausen J, Beer M et al. [Consensus recommendations of the German Radiology Society (DRG), the German Cardiac Society (DGK) and the German Society for Pediatric Cardiology (DGPK) on the use of cardiac imaging with computed tomography and magnetic resonance imaging]. Rofo 2012; 184: 345-368
• 18 Nagel E, Lorenz C, Baer F et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 2001; 3: 267-281
• 19 Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol 1999; 83: 696-702 A7